NCT00810407 Safety And Efficacy Of Rifabutin In Patients For Non-HIV Patients Status COMPLETED Phase N/A
NCT00805272 Medical and Economical Impact of IGRAs Diagnosis of Latent Tuberculosis in HIV-infected Patients Status COMPLETED Phase NA
NCT00802802 Efavirenz (EFV) in HIV-Infected and HIV/Tuberculosis (TB) Coinfected Children Status COMPLETED Phase PHASE1
NCT00801606 Micronutrient Supplementation in in Paediatric Pulmonary Tuberculosis Status COMPLETED Phase PHASE3
NCT00800670 Study of the Safety and Immunogenicity of an Adenovirus-based Tuberculosis Vaccine Status TERMINATED Phase PHASE1
NCT00797836 Quantiferon for Detection of Latent Tuberculosis in Healthcare Workers Status COMPLETED Phase PHASE4
NCT00793702 Safety and Risk of Sensitisation of the rdESAT-6 + rCFP-10 Skin Test Following Repeated Intradermal Administration Status COMPLETED Phase PHASE1
NCT00771498 An Evaluation of the Pharmacological Interaction of Lopinavir/r and Rifampin Status COMPLETED Phase PHASE4
NCT00767975 Active Screening of Latent TB Infection, Treatment and Long Term Follow-up in Prison Status COMPLETED Phase PHASE3
NCT00760149 Pharmacokinetics and Pharmacodynamics of High Versus Standard Dose Rifampicin in Patients With Pulmonary Tuberculosis Status COMPLETED Phase PHASE2
NCT00756808 Is Tuberculin Skin Testing Effective in Screening for Latent Tuberculosis (TB) in Elderly Residents of Nursing Homes? Status COMPLETED Phase N/A
NCT00749034 Dose-Escalation Study on Safety and Immunogenicity of VPM1002 in Comparison With BCG in Healthy Male Volunteers Status COMPLETED Phase PHASE1
NCT00743470 A Bioavailability Study of Rifabutin and Lopinavir/Ritonavir in Healthy Adult Subjects Status TERMINATED Phase PHASE1
NCT00741169 TMC435350-TiDP16-C105: Phase I, 3-way Crossover, Drug-drug Interaction Between TMC435350 and Rifampin After Multiple Dosing. Status COMPLETED Phase PHASE1
NCT00737724 Simultaneous Versus Sequential Antiretroviral Therapy (ARV) Therapy and Mycobacterium Tuberculosis (MTB) Treatment Status TERMINATED Phase NA
NCT00731471 A Phase I Study of a New Tuberculosis (TB) Vaccine, MVA85A, in Healthy Volunteers With HIV Status COMPLETED Phase PHASE1